Thrombolysis with Low-Dose Tissue Plasminogen Activator 3–4.5 h After Acute Ischemic Stroke in Five Hospital Groups in Japan

Ryuta Morihara, Syoichiro Kono, Kota Sato, Nozomi Hishikawa, Yasuyuki Ohta, Toru Yamashita, Kentaro Deguchi, Yasuhiro Manabe, Yoshiki Takao, Kenichi Kashihara, Satoshi Inoue, Hideki Kiriyama, Koji Abe

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Clinical data from Japan on the safety and real-world outcomes of alteplase (tPA) thrombolysis in the extended therapeutic window are lacking. The aim of this study was to assess the safety and real-world outcomes of tPA administered within 3–4.5 h of stroke onset. The study comprised consecutive acute ischemic stroke patients (n = 177) admitted across five hospitals between September 2012 and August 2014. Patients received intravenous tPA within

Original languageEnglish
Pages (from-to)111-119
Number of pages9
JournalTranslational Stroke Research
Volume7
Issue number2
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Tissue Plasminogen Activator
Japan
Stroke
Safety
Therapeutics

Keywords

  • Acute stroke
  • Edaravone
  • Endovascular treatment
  • Intracerebral hemorrhage
  • Recanalization
  • Tissue-type plasminogen activator

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Cardiology and Cardiovascular Medicine

Cite this

Thrombolysis with Low-Dose Tissue Plasminogen Activator 3–4.5 h After Acute Ischemic Stroke in Five Hospital Groups in Japan. / Morihara, Ryuta; Kono, Syoichiro; Sato, Kota; Hishikawa, Nozomi; Ohta, Yasuyuki; Yamashita, Toru; Deguchi, Kentaro; Manabe, Yasuhiro; Takao, Yoshiki; Kashihara, Kenichi; Inoue, Satoshi; Kiriyama, Hideki; Abe, Koji.

In: Translational Stroke Research, Vol. 7, No. 2, 01.04.2016, p. 111-119.

Research output: Contribution to journalArticle

Morihara, Ryuta ; Kono, Syoichiro ; Sato, Kota ; Hishikawa, Nozomi ; Ohta, Yasuyuki ; Yamashita, Toru ; Deguchi, Kentaro ; Manabe, Yasuhiro ; Takao, Yoshiki ; Kashihara, Kenichi ; Inoue, Satoshi ; Kiriyama, Hideki ; Abe, Koji. / Thrombolysis with Low-Dose Tissue Plasminogen Activator 3–4.5 h After Acute Ischemic Stroke in Five Hospital Groups in Japan. In: Translational Stroke Research. 2016 ; Vol. 7, No. 2. pp. 111-119.
@article{4ea2c6b55ada4cc99ef89d2fccdb6bb9,
title = "Thrombolysis with Low-Dose Tissue Plasminogen Activator 3–4.5 h After Acute Ischemic Stroke in Five Hospital Groups in Japan",
abstract = "Clinical data from Japan on the safety and real-world outcomes of alteplase (tPA) thrombolysis in the extended therapeutic window are lacking. The aim of this study was to assess the safety and real-world outcomes of tPA administered within 3–4.5 h of stroke onset. The study comprised consecutive acute ischemic stroke patients (n = 177) admitted across five hospitals between September 2012 and August 2014. Patients received intravenous tPA within",
keywords = "Acute stroke, Edaravone, Endovascular treatment, Intracerebral hemorrhage, Recanalization, Tissue-type plasminogen activator",
author = "Ryuta Morihara and Syoichiro Kono and Kota Sato and Nozomi Hishikawa and Yasuyuki Ohta and Toru Yamashita and Kentaro Deguchi and Yasuhiro Manabe and Yoshiki Takao and Kenichi Kashihara and Satoshi Inoue and Hideki Kiriyama and Koji Abe",
year = "2016",
month = "4",
day = "1",
doi = "10.1007/s12975-016-0448-8",
language = "English",
volume = "7",
pages = "111--119",
journal = "Translational Stroke Research",
issn = "1868-4483",
publisher = "Springer US",
number = "2",

}

TY - JOUR

T1 - Thrombolysis with Low-Dose Tissue Plasminogen Activator 3–4.5 h After Acute Ischemic Stroke in Five Hospital Groups in Japan

AU - Morihara, Ryuta

AU - Kono, Syoichiro

AU - Sato, Kota

AU - Hishikawa, Nozomi

AU - Ohta, Yasuyuki

AU - Yamashita, Toru

AU - Deguchi, Kentaro

AU - Manabe, Yasuhiro

AU - Takao, Yoshiki

AU - Kashihara, Kenichi

AU - Inoue, Satoshi

AU - Kiriyama, Hideki

AU - Abe, Koji

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Clinical data from Japan on the safety and real-world outcomes of alteplase (tPA) thrombolysis in the extended therapeutic window are lacking. The aim of this study was to assess the safety and real-world outcomes of tPA administered within 3–4.5 h of stroke onset. The study comprised consecutive acute ischemic stroke patients (n = 177) admitted across five hospitals between September 2012 and August 2014. Patients received intravenous tPA within

AB - Clinical data from Japan on the safety and real-world outcomes of alteplase (tPA) thrombolysis in the extended therapeutic window are lacking. The aim of this study was to assess the safety and real-world outcomes of tPA administered within 3–4.5 h of stroke onset. The study comprised consecutive acute ischemic stroke patients (n = 177) admitted across five hospitals between September 2012 and August 2014. Patients received intravenous tPA within

KW - Acute stroke

KW - Edaravone

KW - Endovascular treatment

KW - Intracerebral hemorrhage

KW - Recanalization

KW - Tissue-type plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=84959543782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959543782&partnerID=8YFLogxK

U2 - 10.1007/s12975-016-0448-8

DO - 10.1007/s12975-016-0448-8

M3 - Article

VL - 7

SP - 111

EP - 119

JO - Translational Stroke Research

JF - Translational Stroke Research

SN - 1868-4483

IS - 2

ER -